View Author
patient score stent strut syntax study artery syntax score lesion follow-up vessel month trial scaffold plaque disease intervention implantation analysis heart imaging cardiol serruy artery disease outcome sxscore change image percutaneou model baseline intravascular everolimu group ultrasound cardiovasc angiographic risk model bifurcation surgery coherence tomography value euroscore population bioresorbable restenosi figure histology 6- month follow-up tissue treatment syntax trial assessment event cardiology system serruys pw lumen neointimal table result mortality curvature 6 months signi drug-eluting variable fication vessel wall difference device angulation biomarker angiography coherence revascularization tomography diameter registry malapposed struts
10 Most Recent Publications
|
Impact of Overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: Pooled analysis of five trials from the international Global Resolute Program
(Article)
Farooq, V. Vranckx, P. Negoita, M. Leeuwen, A.F. van Neumann, F.J. Yeung, A.C. Garcia-Garcia, H.M. Serruys, P.W.J.C. Mauri, L. Cutlip, D.E. Belardi, J.A. Silber, S. Widimsky, P. Leon, M.B. Windecker, S. Meredith, I. |
2013-05-01
|
|
The SYNTAX score and its clinical implications
(Article)
Head, S.J. Farooq, V. Serruys, P.W.J.C. Kappetein, A.P. |
2013-03-28
|
|
Three-dimensional optical frequency domain imaging in conventional percutaneous coronary intervention: The potential for clinical application
(Article)
Farooq, V. Gogas, B.D. Geuns, R-J.M. van Garcia-Garcia, H.M. Serruys, P.W.J.C. Okamura, T. Heo, J.H. Magro, M. Gomez-Lara, J. Onuma, Y. Radu, M.D. Brugaletta, S. Bochove, G.S. van |
2013-03-21
|
|
Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: Impact on outcome reporting
(Article)
Vranckx, P. Farooq, V. Garg, S.A. Es, G.A. van Silber, S. Windecker, S. Stone, G.W. Serruys, P.W.J.C. |
2012-10-01
|
|
The SYNTAX Score and SYNTAX-Based Clinical Risk Scores
(Article)
Farooq, V. Brugaletta, S. Serruys, P.W.J.C. |
2011-12-08
|
|
Contemporary and evolving risk scoring algorithms for percutaneous coronary intervention
(Article)
Farooq, V. Brugaletta, S. Serruys, P.W.J.C. |
2011-12-01
|
|
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography
(Article)
Gomez-Lara, J. Brugaletta, S. Dudek, D. Smits, P.C. Chevalier, B. Regar, E.S. Veldhof, S. Rapoza, R. Ormiston, J.A. Garcia-Garcia, H.M. Serruys, P.W.J.C. Farooq, V. Onuma, Y. Diletti, R. Windecker, S. Thuesen, L. McClean, D. Koolen, J. Whitbourn, R. |
2011-12-01
|
|
Serial in vivo intravascular ultrasound-based echogenicity changes of everolimus-eluting bioresorbable vascular scaffold during the first 12 months after implantation: Insights from the ABSORB B trial
(Article)
Brugaletta, S. Gomez-Lara, J. Windecker, S. Smits, P.C. Bruyne, B. de Whitbourn, R. Meredith, I. Domburg, R.T. van Sihan, K. Winter, S. de Veldhof, S. Miquel-Hébert, K. Serruys, P.W.J.C. Rapoza, R. Garcia-Garcia, H.M. Ormiston, J.A. Bruining, N. Farooq, V. Geuns, R-J.M. van Thuesen, L. Dudek, D. Koolen, J. Chevalier, B. McClean, D. |
2011-12-01
|
|
Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold
(Article)
Brugaletta, S. Gomez-Lara, J. Whitbourn, R. Meredith, I. Dorange, C. Veldhof, S. Rapoza, R. Ormiston, J.A. Serruys, P.W.J.C. Garcia-Garcia, H.M. Heo, J.H. Farooq, V. Geuns, R-J.M. van Chevalier, B. Windecker, S. McClean, D. Thuesen, L. |
2011-11-24
|
|
Utilizing risk scores in determining the optimal revascularization strategy for complex coronary artery disease
(Article)
Farooq, V. Brugaletta, S. Serruys, P.W.J.C. |
2011-10-01
|
